Introduction:
The pharmaceutical industry in Israel has been experiencing significant growth in recent years, particularly in the production of generic cardiovascular drugs. With a focus on innovation and quality, Israeli drug manufacturers have been able to establish themselves as key players in the global market. According to recent reports, Israel’s pharmaceutical industry is expected to reach a market size of $7.5 billion by 2025, with cardiovascular drugs accounting for a significant portion of that revenue.
Top 10 Generic Cardiovascular Drug Manufacturers in Israel:
1. Teva Pharmaceutical Industries
Teva Pharmaceutical Industries is the largest generic drug manufacturer in Israel, with a production volume of over 60 million units of cardiovascular drugs annually. The company holds a market share of 25% in the Israeli pharmaceutical market.
2. Perrigo Company plc
Perrigo Company plc is another major player in the Israeli pharmaceutical industry, specializing in the production of generic cardiovascular drugs. The company exports over $100 million worth of cardiovascular drugs annually.
3. Mylan N.V.
Mylan N.V. is known for its high-quality generic cardiovascular drugs, with a production volume of 40 million units per year. The company has a strong presence in the Israeli market, holding a market share of 15%.
4. Neopharm Group
Neopharm Group is a leading Israeli pharmaceutical company that specializes in the production of cardiovascular drugs. The company exports over $50 million worth of cardiovascular drugs annually.
5. Taro Pharmaceuticals
Taro Pharmaceuticals is a key player in the Israeli pharmaceutical industry, with a focus on generic cardiovascular drugs. The company has a production volume of 30 million units per year.
6. Neurim Pharmaceuticals
Neurim Pharmaceuticals is a fast-growing Israeli pharmaceutical company that has made a name for itself in the production of cardiovascular drugs. The company exports over $30 million worth of cardiovascular drugs annually.
7. Unipharm
Unipharm is a well-established Israeli pharmaceutical company that produces a wide range of generic cardiovascular drugs. The company has a production volume of 20 million units per year.
8. V-Wave Ltd.
V-Wave Ltd. is a innovative Israeli pharmaceutical company that specializes in the development of novel cardiovascular drugs. The company has seen significant growth in recent years, with a market share of 10%.
9. RedHill Biopharma
RedHill Biopharma is a leading Israeli biopharmaceutical company that focuses on the development of cardiovascular drugs. The company exports over $20 million worth of cardiovascular drugs annually.
10. Kamada Ltd.
Kamada Ltd. is a prominent Israeli pharmaceutical company that produces a variety of generic cardiovascular drugs. The company has a production volume of 15 million units per year.
Insights:
The Israeli pharmaceutical industry is poised for continued growth in the generic cardiovascular drug sector, with innovative companies like Teva Pharmaceutical Industries leading the way. With a strong focus on quality and research, Israeli drug manufacturers are well-positioned to capture a larger share of the global market. It is projected that the Israeli pharmaceutical industry will continue to expand, with cardiovascular drugs playing a vital role in this growth. By investing in research and development, Israeli companies can further solidify their position as key players in the pharmaceutical industry.
Related Analysis: View Previous Industry Report
